Concepedia

Publication | Open Access

Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma

DOIFull Paper Access

65

Citations

24

References

2019

Year

Aya Takahashi, Michihisa Moriguchi, Yuya Seko, Hiroki Ishikawa, Takaharu Yo, Hiroyuki Kimura, Hideki Fujii, Toshihide Shima, Yasuhide Mitsumoto, Hiroshi Ishiba,
Anticancer Research

Abstract

Our results suggest that maintaining an RDI ≥75% during the initial 8 weeks of lenvatinib treatment has a favorable impact on response.

References

YearCitations

Page 1